99 related articles for article (PubMed ID: 23235765)
1. Expression and mutation analyses of Fas, FLIP and Bcl-2 in granulosa cell tumor of ovary.
Yoo NJ; Kim MS; Lee SH
Tumori; 2012; 98(5):118e-121e. PubMed ID: 23235765
[TBL] [Abstract][Full Text] [Related]
2. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
Korkolopoulou P; Goudopoulou A; Voutsinas G; Thomas-Tsagli E; Kapralos P; Patsouris E; Saetta AA
Urology; 2004 Jun; 63(6):1198-204. PubMed ID: 15183989
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of FLIP, an inhibitor of Fas-mediated apoptosis, in stomach cancer.
Lee SH; Kim HS; Kim SY; Lee YS; Park WS; Kim SH; Lee JY; Yoo NJ
APMIS; 2003 Feb; 111(2):309-14. PubMed ID: 12716387
[TBL] [Abstract][Full Text] [Related]
5. GATA-4 regulates Bcl-2 expression in ovarian granulosa cell tumors.
Kyrönlahti A; Rämö M; Tamminen M; Unkila-Kallio L; Butzow R; Leminen A; Nemer M; Rahman N; Huhtaniemi I; Heikinheimo M; Anttonen M
Endocrinology; 2008 Nov; 149(11):5635-42. PubMed ID: 18653721
[TBL] [Abstract][Full Text] [Related]
6. Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence.
Belt EJ; Stockmann HB; Delis-van Diemen PM; Bril H; Tijssen M; van Essen HF; Heymans MW; Beliën JA; Carvalho B; Cillessen SA; Meijer GA
J Surg Oncol; 2014 Mar; 109(3):255-65. PubMed ID: 24249458
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of Fas and FLIP in prostate cancers.
Kim SY; Song SY; Kim MS; Lee JY; Lee HM; Choi HY; Yoo NJ; Lee SH
APMIS; 2009 Jan; 117(1):28-33. PubMed ID: 19161534
[TBL] [Abstract][Full Text] [Related]
8. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
9. Expression of the major fas family and Bcl-2 family of proteins in epithelial ovarian cancer (EOC) and their correlation to chemotherapeutic response and outcome.
Chaudhry P; Srinivasan R; Patel FD
Oncol Res; 2010; 18(11-12):549-59. PubMed ID: 20939431
[TBL] [Abstract][Full Text] [Related]
10. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
[TBL] [Abstract][Full Text] [Related]
11. Fas-mediated apoptosis in neuroblastoma requires mitochondrial activation and is inhibited by FLICE inhibitor protein and Bcl-2.
Poulaki V; Mitsiades N; Romero ME; Tsokos M
Cancer Res; 2001 Jun; 61(12):4864-72. PubMed ID: 11406564
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers.
Kim MS; Hur SY; Yoo NJ; Lee SH
J Pathol; 2010 Jun; 221(2):147-52. PubMed ID: 20198651
[TBL] [Abstract][Full Text] [Related]
13. Molecular manipulation of keratin 8/18 intermediate filaments: modulators of FAS-mediated death signaling in human ovarian granulosa tumor cells.
Trisdale SK; Schwab NM; Hou X; Davis JS; Townson DH
J Ovarian Res; 2016 Feb; 9():8. PubMed ID: 26911253
[TBL] [Abstract][Full Text] [Related]
14. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.
Jamieson S; Alexiadis M; Fuller PJ
Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971
[TBL] [Abstract][Full Text] [Related]
15. Ceramide increases Fas-mediated apoptosis in glioblastoma cells through FLIP down-regulation.
Yoon G; Kim KO; Lee J; Kwon D; Shin JS; Kim SJ; Choi IH
J Neurooncol; 2002 Nov; 60(2):135-41. PubMed ID: 12635660
[TBL] [Abstract][Full Text] [Related]
16. Human RPE expression of cell survival factors.
Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579
[TBL] [Abstract][Full Text] [Related]
17. Resistance to Fas-mediated apoptosis in human lung fibroblast.
Tanaka T; Yoshimi M; Maeyama T; Hagimoto N; Kuwano K; Hara N
Eur Respir J; 2002 Aug; 20(2):359-68. PubMed ID: 12212968
[TBL] [Abstract][Full Text] [Related]
18. The expression of apoptosis-regulatory proteins in B lymphocytes from patients with multiple sclerosis.
Seidi OA; Sharief MK
J Neuroimmunol; 2002 Sep; 130(1-2):202-10. PubMed ID: 12225903
[TBL] [Abstract][Full Text] [Related]
19. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
[TBL] [Abstract][Full Text] [Related]
20. KLF4 expression and apoptosis-related markers in gastric cancer.
Krstic M; Stojnev S; Jovanovic L; Marjanovic G
J BUON; 2013; 18(3):695-702. PubMed ID: 24065485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]